Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19 -: Evidence for a role as a potent basement membrane degrading enzyme

被引:119
|
作者
Stracke, JO [1 ]
Hutton, M
Stewart, M
Pendás, AM
Smith, B
López-Otin, C
Murphy, G
Knäuper, V
机构
[1] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England
[2] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain
[3] Celltech Ltd, Slough SL1 4EN, Berks, England
关键词
D O I
10.1074/jbc.275.20.14809
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently cloned MMP-19 a novel matrix metalloproteinase, which, due to unique structural features, was proposed to represent the first member of a new MMP subfamily (Pendas, A.M., Knauper, V., Puente, X. S., Llano, E., Mattei, M. G., Apte, S., Murphy, G., and Lopez-Otin, C. (1997) J. Biol. Chem. 272, 4281-4286). A recombinant COOH-terminal deletion mutant of MMP-19 (pro Delta(260-508)MMP-19), comprising the propeptide and the catalytic domain, was expressed in Escherichia coli, refolded, and purified. Interestingly, we found that pro Delta(260-508)MMP-19 has the tendency to autoactivate, whereby the Lys(97)-Tyr(98) peptide bond is hydrolyzed, resulting in free catalytic domain. Mutation of two residues (Glu(88), Pro and Pro(90) --> Val) within the propeptide latency motif did not prevent autoactivation but the autolysis rate was somewhat reduced. Analysis of the substrate specificity revealed that the catalytic domain of MMP-19 was able to hydrolyze the general MMP substrate Mca-Pro-Leu-Gly-Dpa-Ala-Arg-NH, and, with higher efficiency, the stromelysin substrate Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2. Kinetic analysis of the interactions of the catalytic domain of MMP-19 with the natural MMP inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), showed strong inhibition using TIMP-2, TIMP-3, and TIMP-4, while TIMP-1 was less efficient. We also demonstrated that synthetic hydroxamic acid-based compounds efficiently inhibited the enzyme. The catalytic domain of MMP-19 was able to hydrolyze the basement membrane components type TV collagen, laminin, and nidogen, as well as the large tenascin-C isoform, fibronectin, and type I gelatin in vitro, suggesting that MMP-19 is a potent proteinase capable of hydrolyzing a broad range of extracellular matrix components. Neither the catalytic domain nor the full-length MMP-19 was able to degrade triple-helical collagen. Finally, and in contrast to studies with other MMPs, MMP-19 catalytic domain was not able to activate any of the latent MMPs tested in vitro.
引用
收藏
页码:14809 / 14816
页数:8
相关论文
共 12 条
  • [1] Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase
    Kolkenbrock, H
    Essers, L
    Ulbrich, N
    Will, H
    BIOLOGICAL CHEMISTRY, 1999, 380 (09) : 1103 - 1108
  • [2] CHARACTERIZATION OF THE MAJOR MATRIX DEGRADING METALLOPROTEINASE OF HUMAN CORNEAL STROMA - EVIDENCE FOR AN ENZYME-INHIBITOR COMPLEX
    BROWN, D
    CHWA, M
    ESCOBAR, M
    KENNEY, MC
    EXPERIMENTAL EYE RESEARCH, 1991, 52 (01) : 5 - 16
  • [3] Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain
    Wang, YH
    Johnson, AR
    Ye, QZ
    Dyer, RD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) : 33043 - 33049
  • [4] Trans-basement membrane migration of human basophils: Role of matrix metalloproteinase-9
    Suzukawa, M.
    Komiya, A.
    Iikura, M.
    Nagase, H.
    Yoshimura-Uchiyama, C.
    Yamada, H.
    Kawasaki, H.
    Ohta, K.
    Matsushima, K.
    Hirai, K.
    Yamamoto, K.
    Yamaguchi, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S50 - S51
  • [5] Trans-basement membrane migration of human basophils: role of matrix metalloproteinase-9
    Suzukawa, Maho
    Komiya, Akiko
    Iikura, Motoyasu
    Nagase, Hiroyuki
    Yoshimura-Uchiyama, Chitose
    Yamada, Hirokazu
    Kawasaki, Hiroshi
    Ohta, Ken
    Matsushima, Kouji
    Hirai, Koichi
    Yamamoto, Kazuhiko
    Yamaguchi, Masao
    INTERNATIONAL IMMUNOLOGY, 2006, 18 (11) : 1575 - 1583
  • [6] Construction, expression, and characterization of a baculovirally expressed catalytic domain of human matrix metalloproteinase-9
    Sadatmansoori, S
    MacDougall, J
    Khademi, S
    Cooke, LS
    Guarino, L
    Meyer, EF
    Forough, R
    PROTEIN EXPRESSION AND PURIFICATION, 2001, 23 (03) : 447 - 452
  • [7] New thiol metalloproteinase inhibitors: an examination of the catalytic domain of membrane-type 1 matrix metalloproteinase in human breast cancer.
    Hurst, DR
    Schwartz, MA
    Ghaffari, MA
    Tschesche, H
    Sang, QXA
    FASEB JOURNAL, 2001, 15 (04): : A539 - A539
  • [8] Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane
    Xia, MH
    Sreedharan, SP
    Dazin, P
    Damsky, CH
    Goetzl, EJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1996, 61 (03) : 452 - 458
  • [9] Human membrane-type 4 matrix metalloproteinase (MMM-17) catalytic domain (CD) is an active pretense.
    Wang, Y
    Johnson, AR
    Ye, OZ
    Streicher, S
    Dyer, RD
    FASEB JOURNAL, 1999, 13 (07): : A1535 - A1535
  • [10] The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding - Binding properties of recombinant gelatinase a C domain to extracellular matrix and basement membrane components
    Wallon, UM
    Overall, CM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) : 7473 - 7481